Detailed Information on Publication Record
2022
Prenylated Flavonoids in Topical Infections and Wound Healing
SYCHROVÁ, Alice, Gabriela ŠKOVRANOVÁ, Marie ČULENOVÁ and Silvia BITTNER FIALOVÁBasic information
Original name
Prenylated Flavonoids in Topical Infections and Wound Healing
Authors
SYCHROVÁ, Alice (203 Czech Republic, guarantor, belonging to the institution), Gabriela ŠKOVRANOVÁ (703 Slovakia, belonging to the institution), Marie ČULENOVÁ (203 Czech Republic, belonging to the institution) and Silvia BITTNER FIALOVÁ
Edition
Molecules, Basel, MDPI, 2022, 1420-3049
Other information
Language
English
Type of outcome
Článek v odborném periodiku
Field of Study
30104 Pharmacology and pharmacy
Country of publisher
Switzerland
Confidentiality degree
není předmětem státního či obchodního tajemství
References:
Impact factor
Impact factor: 4.600
RIV identification code
RIV/00216224:14160/22:00126963
Organization unit
Faculty of Pharmacy
UT WoS
000832513100001
Keywords in English
antibacterial; anti-inflammatory; antioxidant; cytotoxicity; mastitis; MRSA; nanotechnology; prenylated flavonoids; S; aureus; skin; wound healing
Tags
International impact, Reviewed
Změněno: 19/10/2022 18:00, JUDr. Sabina Krejčiříková
Abstract
V originále
The review presents prenylated flavonoids as potential therapeutic agents for the treatment of topical skin infections and wounds, as they can restore the balance in the wound microenvironment. A thorough two-stage search of scientific papers published between 2000 and 2022 was conducted, with independent assessment of results by two reviewers. The main criteria were an MIC (minimum inhibitory concentration) of up to 32 mu g/mL, a microdilution/macrodilution broth method according to CLSI (Clinical and Laboratory Standards Institute) or EUCAST (European Committee on Antimicrobial Susceptibility Testing), pathogens responsible for skin infections, and additional antioxidant, anti-inflammatory, and low cytotoxic effects. A total of 127 structurally diverse flavonoids showed promising antimicrobial activity against pathogens affecting wound healing, predominantly Staphylococcus aureus strains, but only artocarpin, diplacone, isobavachalcone, licochalcone A, sophoraflavanone G, and xanthohumol showed multiple activity, including antimicrobial, antioxidant, and anti-inflammatory along with low cytotoxicity important for wound healing. Although prenylated flavonoids appear to be promising in wound therapy of humans, and also animals, their activity was measured only in vitro and in vivo. Future studies are, therefore, needed to establish rational dosing according to MIC and MBC (minimum bactericidal concentration) values, test potential toxicity to human cells, measure healing kinetics, and consider formulation in smart drug release systems and/or delivery technologies to increase their bioavailability.